MT1G and renal carcinoma: The GSEA also revealed that high MT1G expression was related to pro-oncogenic signaling pathways such as E2F1 targets, epithelial-mesenchymal transition, and G2M checkpoint, further suggesting that MT1G may act as a relevant gene to suppress ferroptosis and adversely affect the prognosis of renal cancer patients.